The Leading Company in the World, PolarisAIPharma Co., Ltd.!
We have been devoting to all our energies to the development
of new active pharmaceutical ingredient
Research Activities
- HOME
- Research & Development
- Research Activities
| Year | Achievements |
|---|---|
| 2017 |
Antiemetic - Ramosetron hydrochloride Nootropics & Neurotonics - Choline Alfoscerate Diuretic - Azosemide |
| 2016 |
Antiviral - Tenofovir Disoproxil Antidepressant - Duloxetine Hydrochloride Antiasthmatic - Montelukast Sodium |
| 2015 |
Antipsychotic - Aripiprazole Antioxidant - Sodium Selenite Pentahydrate Treatment of BPH - Silodosin New drug intermediate - MPC |
| 2014 |
Antihypertensive - Olmesartan Medoxomil Antiviral - Entecavir Antilipemic - Rosuvastatin Calcium MRI contrast agent - Gadopetetate Dimeglumine |
| 2013 |
Antiulcerative - Lafutidine Antioxidant - Selenious acid Nootropics & Neurotonics - N-acetyl-L-aspartic acid New drug intermediate - BIP |
| 2012 |
Antidepressant - Fluvoxamine Maleate Antilipemic - Pitavastatin Calcium |
| 2011 |
Antihistaminic - Ebastine New drug intermediate - DCP |
| 2010 |
Gastroprokinetic - Mosapride Citrate Hydrate Antihypertensive drugs - Bunazosin |
| 2009 |
Antiulcerants - Rebamipide Antidiabetic - Pioglitazone hydrochloride |
| 2008 | Antiasthmatic - Pranlukast hydrate |
| 2007 |
Drugs for erectile dysfunction - Mirodenafil Hydrochloride Digestive medicine - Magnesium Dimecrotate |
| 2006 |
MRI contrast agent - Gadodiamide Treatment of Urinary Incontinence - Tolterodine L-Tartrate |
| 2005 |
Anticonvulsants - Gabapentin Anticonvulsants - Topiramete |